Flovent
(Fluticasone Propionate)ApprovedSmall molecule
GSKFluticasone propionate is used to reduce inflammation and relieve symptoms of asthma, allergies, and nasal congestion by decreasing swelling in the airways and sinuses.[2] Flovent is currently approved and in use across 37 indications[4].[1]
Flovent is one of 626 small molecule programs targeting Chronic Rhinosinusitis Without Nasal Polyps. It is currently in Approved.
37
Indications
130
Total Trials
6
Active Trials
625
Competitors
Pipeline
Status by Indication[4][1]
Indication
Showing 10 of 37 indications
Competition
Competitive Landscape
1931 competitors in COVID-19
#DrugCompanyPhaseTrials
1Flovent
GSKApproved
Spikevax
ModernaPreclinical
Stivarga
BayerPreclinical
Aimovig
AmgenPreclinical
Aldactone
PfizerPreclinical
Nexavar
BayerPreclinical
Activella
Eli LillyPreclinical
Angiomax
BBaxter Healthcare Corporation
Preclinical
Tricor
JJagotec
Preclinical
Precedex
MMcNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.
Preclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Expected Milestones
Clinical
Trials by Indication[1]
Asthma38 trials
Show 35 more trials
Personalized Treatment Algorithms for Difficult-to-treat Asthma
Completed·—·Phase 2·NCT04179461·21 enrolled
The Effects of Different Long-acting Bronchodilator Medications on Asthma Patients With Different Genetic Variations
Terminated·—·N/A·NCT00706446·255 enrolled
Allergic Rhinitis12 trials
Show 9 more trials
Budesonide Nasal Irrigation Versus Fluticasone Propionate Nasal Spray in Treating Allergic Rhinitis Patients
Completed·—·Phase 4·NCT06858423·360 enrolled
Seasonal Allergic Rhinitis7 trials
Show 4 more trials
Chronic Obstructive Pulmonary Disease6 trials
Show 3 more trials
Effectiveness5 trials
43 more indications
Corticosteroids4 trials
The Effect of Inhaled Corticosteroids on Vocal Fold Nodules in Children
Terminated·—·Phase 1·NCT03040596·2 enrolled
Salmeterol3 trials
MPA2 trials
Chronic Rhinosinusitis2 trials
Treatment2 trials
FLuticasone in cOvid Treatment (FLOT)
Unknown status·UUniversity of Medicine and Pharmacy at Ho Chi Minh City·Phase 2/3·NCT05054322·500 enrolled
Children2 trials
Lip2 trials
Eosinophilic Esophagitis2 trials
SOFEED: Six Food vs. One Food Eosinophilic Esophagitis Diet Study
Completed·—·Phase 2/3·NCT02778867·129 enrolled
Eosinophilic Esophagitis Intervention Trial-1 Food vs. 4 Food Elimination Diet Followed by Swallowed Glucocorticoids
Completed·—·Phase 2/3·NCT02610816·67 enrolled
Acute Lymphoblastic Leukemia1 trial
Outcome1 trial
Nasal Polyps1 trial
Endothelial Function1 trial
Allergic Conjunctivitis1 trial
Blepharitis1 trial
Contact Dermatitis1 trial
Nasal polyposis1 trial
Ketorolac1 trial
Intranasal Administration1 trial
Efficacy and Safety1 trial
T-ALL1 trial
Glaucoma1 trial
Efficacy1 trial
Type 1 Diabetes Mellitus1 trial
The Use of Topical Nasal Steroids for Skin Reactions to Continuous Glucose Monitoring System, Among Children and Youth With Type 1 Diabetes Mellitus: Case Series
Completed·—·Phase 1·NCT03594565·13 enrolled
ESS1 trial
Chronic Asthma1 trial
Atopic Dermatitis1 trial
Sinusitis1 trial
Allergic Rhinitis (AR)1 trial
Evaluation Of The Adjunctive Effects Of Moxibustion In The Treatment Of Cold-Syndrome Allergic Rhinitis
Active, not recruiting·UUniversity of Medicine and Pharmacy at Ho Chi Minh City·Preclinical·NCT07537439·60 enrolled
Unspecified9 trials
Show 6 more trials
Sources
References
- [1]
- [2]MedlinePlus Drug Information — Flovent drug information. U.S. National Library of Medicine, National Institutes of Health.
- [3]
- [4]Open Targets Platform — Drug–disease associations for Fluticasone Propionate. EMBL-EBI & Wellcome Sanger Institute.
- [5]